Old Web
English
Sign In
Acemap
>
authorDetail
>
Michelle Hage
Michelle Hage
Internal medicine
Phases of clinical research
Clinical trial
Tolerability
Medicine
3
Papers
35
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase 1 clinical trial of losmapimod in facioscapulohumeral dystrophy: Safety, tolerability, pharmacokinetics, and target engagement
2021
British Journal of Clinical Pharmacology
Michelle Mellion
Lucienne Ronco
Cécile Berends
Lisa Pagan
Sander Brooks
Michiel J. van Esdonk
Emilie M.J. van Brummelen
Adefowope Odueyungbo
Lorin A. Thompson
Michelle Hage
Umesh A. Badrising
Shane Raines
William G Tracewell
Baziel G.M. van Engelen
Diego Cadavid
Geert Jan Groeneveld
Show All
Source
Cite
Save
Citations (0)
Phase 1 Clinical Trial of Losmapimod in Facioscapulohumeral Muscular Dystrophy (FSHD): Safety, Tolerability, and Target Engagement (1557)
2020
Neurology
Michelle Mellion
Lucienne Ronco
Lorin A. Thompson
Michelle Hage
Sander Brooks
Emilie M.J. van Brummelen
Lisa Pagan
Umesh A. Badrising
Shane Raines
William Tracewell
Baziel G.M. van Engelen
Geert Jan Groeneveld
Diego Cadavid
Show All
Source
Cite
Save
Citations (1)
c-Jun NH2-Terminal Kinase Activity in Subcutaneous Adipose Tissue but Not Nuclear Factor-κB Activity in Peripheral Blood Mononuclear Cells Is an Independent Determinant of Insulin Resistance in Healthy Individuals
2009
Diabetes
Karly C. Sourris
Jasmine Lyons
Maximilian de Courten
Sonia L Dougherty
Darren C. Henstridge
Mark E. Cooper
Michelle Hage
Anthony M. Dart
Bronwyn A. Kingwell
Josephone M Forbes
Barbora de Courten
Show All
Source
Cite
Save
Citations (34)
1